The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

A recent study published in Engineering delves into the advancements in wound management, specifically focusing on ...

Health care has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

The Outsourcing Facilities Association filed two lawsuits against the FDA about the removal of Tirzepatide and Semaglutide ...

Attorney General Dave Sunday is warning Pennsylvanians to make sure they're using licensed pharmacies for GLP-1 drugs amid a ...

Kenya is among the low- and middle-income countries (LMICs) whose children and young people (CYP) face gross inequities when it comes to the diagnosis and treatment of type 1 diabetes (T1D). These are ...

President Donald Trump, center, gestures as he prepares to leave with Dr. Mehmet Oz, left, Administrator of the Centers for ...

Kenya ranks 44th among 113 low- and middle-income countries in the prevalence of type 1 diabetes among children and young ...